Advances in inducing adaptive immunity using cell-based cancer vaccines: Clinical applications in pancreatic cancer

The incidence of pancreatic ductal adenocarcinoma (PDA) is on the rise, and the prognosis is extremely poor because PDA is highly aggressive and notoriously difficult to treat. Although gemcitabine- or 5-fluorouracil-based chemotherapy is typically offered as a standard of care, most patients do not...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:World J Gastroenterol
Autors principals: Kajihara, Mikio, Takakura, Kazuki, Kanai, Tomoya, Ito, Zensho, Matsumoto, Yoshihiro, Shimodaira, Shigetaka, Okamoto, Masato, Ohkusa, Toshifumi, Koido, Shigeo
Format: Artigo
Idioma:Inglês
Publicat: Baishideng Publishing Group Inc 2016
Matèries:
Topic Highlight
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4858628/
https://ncbi.nlm.nih.gov/pubmed/27182156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v22.i18.4446
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars